SIREXATAMAB
UNII RM898LZ4SI

Substance Identification & Data

This profile provides standardized clinical and technical data for Sirexatamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RM898LZ4SI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2414962-49-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RM898LZ4SI

CAS Registry Number

2414962-49-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIREXATAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C99123

National Cancer Institute reference terminology for clinical and research data.

INN ID

11751

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sirexatamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIREXATAMAB

Common Names & Synonyms

ANTI-DKK-1 MONOCLONAL ANTIBODY LY2812176

DKK1-NEUTRALIZING MONOCLONAL ANTIBODY DKN-01

HUMANISED IGG4 ANTI DICKKOPF-1 PROTEIN MONOCLONAL ANTIBODY DKN-01

IMMUNOGLOBULIN G4 (224-PROLINE,233-ALANINE,234-ALANINE), ANTI-(HUMAN DICKKOPF-1) (HUMAN-MUS MUSCULUS MONOCLONAL DKN-01 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL DKN-01 .KAPPA.-CHAIN, DIMER

SIREXATAMAB [INN]

SIREXATAMAB [WHO-DD]